Post-stent chest pain, revisited
Heart Sisters
JULY 28, 2024
Heart patients with persistent or recurrent post-stent chest pain present “an unmet clinical need”, according to the European Journal of Cardiology.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Heart Sisters
JULY 28, 2024
Heart patients with persistent or recurrent post-stent chest pain present “an unmet clinical need”, according to the European Journal of Cardiology.
DAIC
JUNE 4, 2024
This new system combines a truly innovative stent design,” said Dr. Ramaiah, a former director of the Arizona Heart Hospital. “We She already has three stents in her heart and so many stents and replacement arteries in both her legs that she’s lost count. The physician who performed the procedure, Venkatesh Ramaiah, M.D.,
Med Page Today
APRIL 8, 2024
(MedPage Today) -- ATLANTA -- The concept of using stents to seal off non-flow-limiting vulnerable plaques, before they have a chance to rupture, worked out in the first major trial testing this provocative idea. Compared with standard medical.
JAMA Cardiology
OCTOBER 8, 2024
This systematic review and network meta-analysis investigates the optimal duration of dual antiplatelet therapy in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention with drug-eluting stents.
DAIC
APRIL 17, 2024
milla1cf Wed, 04/17/2024 - 16:18 April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered stent system, which has been on the market for twenty years and recently received premarket approval for treatment of iliac arterial occlusive disease.
Medical Xpress - Cardiology
FEBRUARY 21, 2024
Using intravascular imaging to guide stent implantation during percutaneous coronary intervention (PCI) in heart disease patients significantly improves survival and reduces adverse cardiovascular events compared to angiography-guided PCI alone, the most commonly used method.
American College of Cardiology
SEPTEMBER 2, 2024
The goal of the REC-CAGEFREE I trial was to assess the safety and efficacy of a paclitaxel-coated balloon (DCB) compared to drug-eluting stent (DES) implantation among patients with coronary in-stent restenosis.
Becker's Hospital Review - Cardiology
JUNE 3, 2024
based HonorHealth Research and Innovation Institute is among the first facilities in the nation — and one of 30 worldwide — to use new stroke prevention stents, according to a May 29 news release. Scottsdale, Ariz.-based
Frontiers in Cardiovascular Medicine
JULY 25, 2024
The past five years have yielded impressive advancements in fully absorbable metal stent technology. Nowhere is the need for fully absorbable metal stents greater than in patients experiencing vascular anomalies associated with congenital heart disease (CHD).
Dr. Paddy Barrett
DECEMBER 5, 2023
The logic of stenting obstructed coronary arteries is simple. A stent unblocks the artery. Subscribe now Stenting stable coronary artery disease has not been convincingly proven to reduce the risk of future heart attacks or death 1. But coronary stenting is not the only way to reduce symptoms of angina. All is fixed.
DAIC
APRIL 16, 2024
While PCI, which includes both angioplasty and stenting, is one of the most common operations in the world, it does carry a small (about 1-2%) but significant risk of death. in total, angioplasty and stenting was deemed to be of low value and potentially avoidable nearly one third of the time.
Cardiology Update
JULY 28, 2024
A recent study published in JACC: Cardiovascular Interventions has provided new insights into the long-term management of patients suffering from recurrent in-stent restenosis (ISR), a condition presenting notable challenges in cardiovascular treatment. The median follow-up period was 10.3 Original article: Koch T et al.
Becker's Hospital Review - Cardiology
JUNE 20, 2024
based Atrium Health Sanger Heart & Vascular Institute has become the first in the world to implant a new Duo venous stent system. Charlotte, N.C.-based
Medical Xpress - Cardiology
JANUARY 17, 2024
By inflating a balloon and potentially placing a stent, they can help blood flow more freely from the heart. When a person has one or more blocked arteries, providers may choose to conduct a minimally invasive procedure known as percutaneous coronary intervention, or PCI.
Med Page Today
JULY 25, 2024
(MedPage Today) -- For interventionalists hoping that a new generation of coronary balloons might improve treatment of in-stent restenosis (ISR), contemporary registry data were encouraging. In a propensity score-matched analysis of 335 pairs.
Circulation: Cardiovascular Interventions
JANUARY 15, 2024
BACKGROUND:We previously reported the use of minimal stent area to predict angiographic in-stent restenosis after drug-eluting stent implantation for unprotected left main (LM) disease. Circulation: Cardiovascular Interventions, Volume 17, Issue 1 , Page e013006, January 1, 2024. mm2for distal LM (area under the curve, 0.57;P=0.15),
JAMA Cardiology
MARCH 12, 2024
This randomized clinical trial compares 12-month event rates using quantitative coronary angiography guidance during percutaneous coronary intervention with those after intravascular ultrasonography–guided stent implantation.
DAIC
MARCH 8, 2024
a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States. New tapered configurations for our ENROUTE Transcarotid Stent System build upon the robust portfolio of Silk Road’s carotid solutions.
Open Heart
JANUARY 19, 2024
Aims To estimate the 1-year cost-effectiveness of stepwise provisional versus systematic dual stenting strategies. Aims To estimate the 1-year cost-effectiveness of stepwise provisional versus systematic dual stenting strategies. Uncertainty was explored by probabilistic bootstrapping.
American College of Cardiology
SEPTEMBER 2, 2024
The goal of the INFINITY-SWEDEHEART trial was to compare the efficacy of the DynamX bioadaptor, a novel coronary implantable device, to a contemporary drug-eluting stent (DES) in the treatment of coronary artery disease requiring percutaneous coronary intervention (PCI).
Dr. Paddy Barrett
NOVEMBER 28, 2023
One of the most common questions I get is, “ Do I need a stent to treat my heart disease?” ” Typically, several of this person’s friends have had stents, so it seems natural to ask. First, we must understand what a stent is and why it is used. The stent ‘unblocks’ it. Flow is restored.
Stroke Journal
FEBRUARY 1, 2024
Background:In stroke patients undergoing EVT, angioplasty and stenting (A&S) has been described as a bailout technique when thrombectomy fails or intracranial stenosis is suspected. The stent-retriever was re-sheathed into the microcatheter before retrieval. Additionally, 10-15 ml of tirofiban were administered intravenously.
Medical Xpress - Cardiology
SEPTEMBER 2, 2024
Novel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the first randomized trial to compare clinical outcomes in previously untreated patients with non-complex disease undergoing percutaneous coronary intervention (PCI).
Science Daily - Heart Disease
APRIL 8, 2024
New research could change standard-of-care guidelines to improve outcomes for heart attack patients after coronary stenting procedures.
American College of Cardiology
SEPTEMBER 2, 2024
A strategy of drug-coated balloon (DCB) angioplasty with rescue stenting did not achieve noninferiority compared with intended drug-eluting stent (DES) deployment for patients with de novo, noncomplex coronary artery lesions, according to finding from the REC-CAGEFREE I trial presented at ESC Congress 2024 in London and simultaneously published in (..)
Frontiers in Cardiovascular Medicine
FEBRUARY 18, 2024
Drug-eluting stents (DES) play a crucial role in treating coronary artery disease (CAD) by preventing restenosis. These stents are coated with drug carriers that release antiproliferative drugs within the vessel. The most cited document pertained to standardized definitions for clinical endpoints in coronary stent trials.
Frontiers in Cardiovascular Medicine
JANUARY 7, 2024
Introduction The use of contemporary drug-eluting stents (DES) has significantly improved outcomes of patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). cases, the target lesion was in-stent restenosis (ISR). Results A total of 425 patients were enrolled at 13 centers (mean age 66.9 ± 11.6
Frontiers in Cardiovascular Medicine
MAY 13, 2024
Due to the implantation technique, left pulmonary artery (LPA) stents represent a relative contraindication to Venus P-valve. 3/16 (18.7%) patients underwent Venus P-valve implantation with LPA stents. 3/16 (18.7%) patients underwent Venus P-valve implantation with LPA stents. Valve implantation is technically challenging.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
IntroductionDrug‐eluting stent (DES) use in symptomatic intracranial atherosclerosis disease (ICAD) has been described in the literature using different guiding and distal access catheters. Decision was made to deploy a drug eluting stent into the stenosed M1 segment. The Phenom intermediate catheter was then removed, and the 2.25
Frontiers in Cardiovascular Medicine
MARCH 12, 2024
In this phenomenon, a thrombus forms within the lumen of the stent graft component of the frozen elephant trunk prosthesis and puts the patient at risk for downstream embolization with visceral or lower limb ischemia. The long-term efficiency of these prophylactic and therapeutic measures has yet to be proven.
Dr. Prateek Bhatnagar
SEPTEMBER 6, 2023
Prateek Bhatnagar Director Cardiac Surgery, on a 50 years man after stents placed in his left main coronary artery at Delhi just 3 months back, had blocked. He subsequently underwent stenting procedure in left main coronary artery. However, within 3 months of stenting, he developed increasing chest pain.
Becker's Hospital Review - Cardiology
DECEMBER 20, 2023
Cardiologists are speaking out against a Lown Institute report that alleged 1 in 5 stents placed in Medicare recipients were considered "overuse," Medscape reported Dec.
Frontiers in Cardiovascular Medicine
JANUARY 7, 2024
In the present case, a 76-year-old hypertensive woman was admitted with dizziness and diagnosed with an unruptured bronchial artery aneurysm, which was treated by transcatheter arterial embolization and aortic stent-graft. The patient's clinical status was stable during the 4-year follow-up.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Rescue treatment with stenting, balloon angioplasty, and/or intraarterial thrombolysis or antiplatelets are often required to treat the underlying stenosis. 4 Recent literature has reported clinical benefits associated with rescue stenting in the setting of ICAD‐related MT‐refractory strokes.5
Frontiers in Cardiovascular Medicine
DECEMBER 21, 2023
Background In acute coronary syndrome (ACS), a number of previous studies tried to identify the risk factors that are most likely to influence the rate of in-stent restenosis (ISR), but the contribution of these factors to ISR is not clearly defined.
Journal of Cardiothoracic Surgery
MARCH 4, 2024
To observe the occurrence of related complications after self-expandable metallic (SEM) airway stents implantation with different diameters at different time points, and to provide theoretical basis for the op.
Stroke Journal
FEBRUARY 1, 2024
In cases of stent-retriever thrombectomy failure, rescue stent angioplasty might be the sole option for achieving permanent recanalization. Among patients who underwent emergency intracranial stenting, 66 (30.6%) received intravenous thrombolytic treatment. 10.43, p=0.0325).Conclusions:The 10.43, p=0.0325).Conclusions:The
Med Page Today
SEPTEMBER 1, 2024
(MedPage Today) -- LONDON -- Some individuals already undergoing transcatheter aortic valve replacement (TAVR, also TAVI) might as well get coronary lesions revascularized around the same time, according to the NOTION-3 randomized trial. Clinical.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
The role of intracranial stenting in ICAS remains uncertain. In the SAMMPRIS trial, patients who had experienced recent TIA/CVA secondary to 70‐99% ICAS demonstrated an increased risk of recurrent stroke when treated with angioplasty and stenting compared to medical therapy alone [1].
Stroke Journal
FEBRUARY 1, 2024
Background:There is limited data regarding the comparison of balloon-expanding stents (BES) and self-expanding stents (SES) for the treatment of intracranial arterial stenosis.Methods:We conducted a systematic review to identify studies that compared SES and BES in patients with symptomatic intracranial arterial stenosis.
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
IntroductionCombined technique mechanical thrombectomy with contact aspiration with stent‐retriever has been shown to lead to comparable final reperfusion rates compared with stent retriever alone. Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. The SR group had higher IV‐tPA use (41.9%vs.26.1%,P=0.04),
Stroke: Vascular and Interventional Neurology
FEBRUARY 6, 2024
OBJECTIVECarotid artery stenting for heavily calcified lesions is challenging for interventionists. Sufficient dilatation was achieved, followed by carotid stent deployment (Precise Pro RX; Cordis, Miami Lakes, FL, USA). Stroke: Vascular and Interventional Neurology, Ahead of Print.
Stroke: Vascular and Interventional Neurology
NOVEMBER 2, 2023
Transverse sinus stenting is a new effective treatment for IIH. The patient underwent venous sinus stenting for fulminant IIH. Her child displayed no signs and symptoms of abnormalities.ConclusionVenous sinus stenting for IIH can be considered in pregnant patients presenting with new or worsening IIH with associated papilledema.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content